-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics names Penny Carlson SVP, Development Operations

PUBT·06/08/2026 20:01:25
Listen to the news
Kymera Therapeutics names Penny Carlson SVP, Development Operations
  • Kymera Therapeutics appointed Penny Carlson as senior vice president, development operations to lead global clinical development operations for its oral immunology portfolio.
  • Carlson previously served as vice president and head of global clinical development operations at Takeda, overseeing planning and execution of clinical trials.
  • She earlier held leadership roles at Millennium Pharmaceuticals, Aileron Therapeutics, and other drugmakers.
  • Chief Operating Officer Jeremy Chadwick will retire, remaining an adviser through year-end.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606081601PRIMZONEFULLFEED9733408) on June 08, 2026, and is solely responsible for the information contained therein.